A subset of neutrophils as a predictive biomarker for immunotherapy response in patients with non-small-cell lung cancer and melanoma

被引：0
|
作者：
Shaked, Yuval
Benguigui, Madeleine
Halaban, Ruth
Bacchiocchi, Antonella
Kamer, Iris
Bar, Jair
Lotem, Michal
Shen-Orr, Shai
Sznol, Mario
Cooper, Tim J.
机构：
[1] Technion, Haifa, Israel
[2] Technion Israel Inst Technol, Haifa, Israel
[3] Yale Sch Med, New Haven, CT USA
[4] Yale Univ, Sch Med, New Haven, CT USA
[5] Inst Oncol, Sheba Med Ctr, Ramat Gan, Israel
[6] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[7] Yale Univ, Yale New Haven Hosp, Smilow Canc Hosp, Yale Canc Ctr,Sch Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
欧洲研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2557
引用
收藏
页数：1
相关论文
共 50 条
  • [1] 18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy
    Evangelista, Laura
    Cuppari, Lea
    Menis, Jessica
    Bonanno, Laura
    Reccia, Pasquale
    Frega, Stefano
    Pasello, Giulia
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (08) : 802 - 807
  • [2] TIME for biomarker-driven immunotherapy in non-small-cell lung cancer patients
    Karachaliou, Niki
    Rosell, Rafael
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (02) : 127 - 130
  • [3] Immunotherapy in frail non-small-cell lung cancer patients
    Gijtenbeek, Rolof G. P.
    Noordhof, Anneloes L.
    Asmara, Oke D.
    Groen, Harry J. M.
    van Geffen, Wouter H.
    LANCET, 2024, 403 (10440): : 1986 - 1986
  • [4] Immunotherapy rechallenge in patients with non-small-cell lung cancer
    Espana, S.
    Guasch, I.
    Carcereny, E.
    PULMONOLOGY, 2020, 26 (04): : 252 - 254
  • [5] Immunotherapy of non-small-cell lung cancer
    Reinmuth, Niels
    Merk, Martina
    Duell, Thomas
    ONKOLOGE, 2021, 27 (02): : 179 - 190
  • [6] Immunotherapy for non-small-cell lung cancer
    Thomas, Anish
    Jakopovic, Marko
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (08) : 1061 - 1064
  • [7] Hypertension as a predictive biomarker in patients with advanced non-small-cell lung cancer treated with apatinib
    Fang, Shen-Cun
    Huang, Wen
    Zhang, Ying-Ming
    Zhang, Hai-Tao
    Xie, Wei-Ping
    ONCOTARGETS AND THERAPY, 2019, 12 : 985 - 992
  • [8] Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
    Hellmann, Matthew D.
    Nathanson, Tavi
    Rizvi, Hira
    Creelan, Benjamin C.
    Sanchez-Vega, Francisco
    Ahuja, Arun
    Ni, Ai
    Novik, Jacki B.
    Mangarin, Levi M. B.
    Abu-Akeel, Mohsen
    Liu, Cailian
    Sauter, Jennifer L.
    Rekhtman, Natasha
    Chang, Eliza
    Callahan, Margaret K.
    Chaft, Jamie E.
    Voss, Martin H.
    Tenet, Megan
    Li, Xue-Mei
    Covello, Kelly
    Renninger, Andrea
    Vitazka, Patrik
    Geese, William J.
    Borghaei, Hossein
    Rudin, Charles M.
    Antonia, Scott J.
    Swanton, Charles
    Hammerbacher, Jeff
    Merghoub, Taha
    McGranahan, Nicholas
    Snyder, Alexandra
    Wolchok, Jedd D.
    CANCER CELL, 2018, 33 (05) : 843 - +
  • [9] A Review of Immunotherapy in Non-Small-Cell Lung Cancer
    Capella, Mariana Pilon
    Pang, Steph A.
    Magalhaes, Marcos A.
    Esfahani, Khashayar
    CURRENT ONCOLOGY, 2024, 31 (06) : 3495 - 3512
  • [10] Predictive Toxicity and Response to Immunotherapy in Patients with Metastatic Non Small Cell Lung Cancer (IMMUNOPREDICT)
    Nguyen, J.
    Quere, G.
    Descourt, R.
    Geier, M.
    Babey, H.
    Saliou, P.
    Picard, J.
    Dhamelincourt, E.
    Fave, T.
    Laune, Q.
    Simaki, A.
    Renaud, E.
    Cornec, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S618 - S618
12345